Trial NCT01146561

View at ClinicalTrials.gov 
Org. Study IDs: A4091044
Secondary IDs: 2010-019012-21 CHRONIC PANCREATITIS POC STUDY

Last trial update was posted on 2021-03-23

MeSH Interventions

Tanezumab

MeSH Conditions

Pancreatitis Pancreatitis, Chronic

Other Conditions

Chronic Pancreatitis

Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to FDA clinical hold, the study was prematurely terminated with only 2 participants were enrolled and randomized to placebo treatment and hence, efficacy and pharmacokinetic analysis was not performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID